Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

@article{Travis2002LungCF,
  title={Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.},
  author={Lois B Travis and Mary Krystyna Gospodarowicz and Rochelle E Curtis and E Aileen Clarke and Michael Andersson and Bengt Glimelius and Timo Joensuu and Charles F. Lynch and Flora E. van Leeuwen and Eric J. Holowaty and Hans Henrik Storm and Ingrid Glimelius and Eero Pukkala and Marilyn A Stovall and Joseph F. Jr. Fraumeni and John D. Boice and Ethel S. Gilbert},
  journal={Journal of the National Cancer Institute},
  year={2002},
  volume={94 3},
  pages={
          182-92
        }
}
BACKGROUND Lung cancer is a frequent cause of death in patients cured of Hodgkin's disease, but the contributions of chemotherapy, radiotherapy, and smoking are not well described. We quantified the risk of treatment-associated lung cancer, taking into account tobacco use. METHODS Within a population-based cohort of 19 046 Hodgkin's disease patients (diagnosed from 1965 through 1994), a case-control study of lung cancer was conducted. The cumulative amount of cytotoxic drugs, the radiation… Expand

Paper Mentions

Interventional Clinical Trial
The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal… Expand
ConditionsHodgkin Lymphoma
InterventionRadiation
Lung cancer after treatment for Hodgkin's lymphoma: a systematic review.
TLDR
It is shown that risk of lung cancer is significantly increased in patients treated for Hodgkin's lymphoma, with a reported mean relative risk of 2.6-7.0 and a significantly increased absolute excess risk. Expand
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
TLDR
The substantial risk reduction associated with CT may reflect its effect on menopausal age, suggesting that ovarian hormones promote tumorigenesis after radiation has produced an initiating event. Expand
Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment
TLDR
The results agree with previous studies in favor of an increased risk of lung cancer after radiation therapy for breast cancer. Expand
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
TLDR
Stomach cancer risk is strongly radiation dose dependent, and the role of chemotherapy, particularly of procarbazine and related agents, needs further study, because of the relatively small numbers of chemotherapy-treated subjects. Expand
Pancreatic cancer risk after treatment of Hodgkin lymphoma.
  • G. Dores, R. Curtis, +22 authors E. Gilbert
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2014
TLDR
It is demonstrated for the first time that both radiotherapy and chemotherapy substantially increase pancreatic cancer risks among Hodgkin lymphoma survivors treated in the past and add to the evidence that the combination of radi therapy and chemotherapy can lead to especially large risks. Expand
Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma
TLDR
It was found that cyclophosphamide-based therapy increased the risk of SMN in NHL and leukemia risk was linked with high-dose cycloph phosphamide. Expand
Clinical course of thoracic cancers in Hodgkin's disease survivors.
TLDR
Most patients with thoracic cancers after Hodgkin's disease have a history of exposure to risk factors and present at an advanced stage, and patients with patients with NSCLC and a known stage have a poor survival. Expand
Stomach cancer risk after treatment for hodgkin lymphoma.
TLDR
Patients with HL who received subdiaphragmatic radiotherapy had dose-dependent increased risk of stomach cancer, with marked risks for patients who also received chemotherapy containing high-dose procarbazine. Expand
Risk of second primary lung cancer in women after radiotherapy for breast cancer.
TLDR
Second lung cancer after radiotherapy for early breast cancer is associated with the delivered dose to the lung, and the growing number of long-time survivors after breast cancer treatment highlights the need for advances in normal tissue sparing radiation techniques. Expand
Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
TLDR
Half of the patients die of aggressive NHL before living long enough to experience second cancer, and only young patients have a high risk of second cancer during follow-up beyond 10 years. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
TLDR
The excess risk of lung cancer in Hodgkin's disease patients treated with radiotherapy is related to the radiation dose received by the affected area of the lung, andSmokers experience a significantly greater risk attributable to radiotherapy than nonsmokers. Expand
Lung cancer following Hodgkin′s disease: A case‐control study
TLDR
A plausible inference from the study is that all forms of Hodgkin's disease therapy are carcinogenic to the lung and that chemotherapy is associated with an increase in risk which is at least comparable to and perhaps higher than the risk produced by radiotherapy. Expand
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
TLDR
The results suggest that MOPP chemotherapy may lead to elevated risk of lung cancer, at least in certain subgroups of patients, and the role of chemotherapy in the etiology of Lung cancer after Hodgkin's disease deserves further investigation. Expand
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.
TLDR
The strong dose-response relationship and high absolute risk of bladder cancer underscore the importance of limiting the cumulative dose of cyclophosphamide to what is required to achieve therapeutic end points. Expand
Treatment-associated leukemia following testicular cancer.
TLDR
Past treatments for testicular cancer are associated with an increased risk of leukemia, with evidence for dose-response relationships for both radiotherapy and cisplatin-based chemotherapy. Expand
Lung cancer risk and radiation dose among women treated for breast cancer.
TLDR
Current radiotherapy for breast cancer results in less extensive exposure of the lungs in comparison to treatments of years past, and the risk of secondary lung cancer need not play a major role in clinical decisions regarding treatment for Breast cancer. Expand
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.
TLDR
Because of their substantially increased risk, survivors of developing second primary cancers other than small-cell lung carcinoma should stop smoking and may consider entering trials of secondary chemoprevention. Expand
Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
TLDR
Platinum-based treatment of ovarian cancer increases the risk of secondary leukemia, but the substantial benefit that platinum- based treatment offers patients with advanced disease outweighs the relatively small excess risk of leukemia. Expand
Hodgkin's disease: complications of therapy and excess mortality.
  • R. Hoppe
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 1997
TLDR
The absolute excess risk of death from causes other than Hodgkin's disease increases during each five-year follow-up interval for at least 25 years, but is less for patients treated in more recent years (1980-1995) than in the prior treatment era (1962-1980). Expand
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
TLDR
Since the number of CT episodes was found to be a strong determinant of leukemia risk, it is important that new therapies for HD continue to yield high initial cure rates. Expand
...
1
2
3
4
5
...